These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21843660)

  • 21. Intravenous Immunoglobulin in the Treatment of Hematologic Disorders in Pediatrics.
    Villanueva G; de Jong JL; McNeer JL
    Pediatr Ann; 2017 Jan; 46(1):e13-e18. PubMed ID: 28079913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and comparison of adverse events for preparations of IVIG in patients with neuromuscular diseases.
    Nadeau JO; Bhibhatbhan A; McDougall D; Toth C
    Clin Neurol Neurosurg; 2010 Jul; 112(6):467-9. PubMed ID: 20227821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adverse effects of administration of intravenous human immunoglobulins].
    Bednarík J; Kadanka Z
    Cas Lek Cesk; 1999 Nov; 138(21):647-9. PubMed ID: 10746020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoregulation of autoimmune disorders: the role of intravenous immunoglobulins.
    Luzi G; Ferrara R
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():189-95. PubMed ID: 8013987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematologic adverse effects of clopidogrel.
    Balamuthusamy S; Arora R
    Am J Ther; 2007; 14(1):106-12. PubMed ID: 17303978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous immunoglobulins in neurological disorders: safety issues.
    Eibl MM
    Neurol Sci; 2003 Oct; 24 Suppl 4():S222-6. PubMed ID: 14598047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases.
    Mignogna MD; Fortuna G; Leuci S; Ruoppo E; Adamo D; Fedele S
    Clin Exp Dermatol; 2009 Mar; 34(2):145-50. PubMed ID: 19187294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Old and current aspects of intravenous immunoglobulin therapy].
    Nydegger U
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):5-25. PubMed ID: 8296191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of liquid intravenous immunoglobulin for neuroimmunologic disorders in the home setting: a retrospective analysis of 1085 infusions.
    Rigas M; Tandan R; Sterling RJ
    J Clin Neuromuscul Dis; 2008 Dec; 10(2):52-5. PubMed ID: 19169090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
    Francioni C; Fioravanti A; Gelli R; Megale F; Marcolongo R
    Recenti Prog Med; 1993 Oct; 84(10):679-86. PubMed ID: 8235034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proposed relationship between intravenous immunoglobulin and thrombosis in renal transplant recipients.
    Duronio A; Bajjoka I; Hsaiky L; Parasuraman R
    Ann Pharmacother; 2007 Feb; 41(2):354-8. PubMed ID: 17264157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side-effects of intravenous immune globulins.
    Duhem C; Dicato MA; Ries F
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders.
    Mobini N; Sarela A; Ahmed AR
    Ann Allergy Asthma Immunol; 1995 Feb; 74(2):119-28; quiz 128-33. PubMed ID: 7697470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
    Barsheshet A; Marai I; Appel S; Zimlichman E
    Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature.
    Hefer D; Jaloudi M
    Ann Hematol; 2004 Oct; 83(10):661-5. PubMed ID: 15309520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematologic toxicities of small molecule tyrosine kinase inhibitors.
    Barber NA; Afzal W; Akhtari M
    Target Oncol; 2011 Dec; 6(4):203-15. PubMed ID: 22127751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunoglobulins--merely expensive or also useful?].
    Paar WD
    Ther Umsch; 1995 Oct; 52(10):639-44. PubMed ID: 7482374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion.
    Welles CC; Tambra S; Lafayette RA
    Am J Kidney Dis; 2010 Jan; 55(1):148-51. PubMed ID: 19628320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.